InsidersTradesSigma
Apotea AB (publ): insider trades · Finland · FIN-FSA
FI:apotea-ab-publSE0023313762FI·FIN-FSAMcap 7.9Bn€Healthcare
Discover the full directors' dealings record of Apotea AB (publ), a publicly traded company based in Finland. Shares are quoted on FI FI, under the supervision of FIN-FSA. Operating in the Healthcare sector, Apotea AB (publ) has logged 3 public disclosures. Market capitalisation: €7.9bn. The latest transaction was filed on 18 March 2026 — Purchase. Among the most active insiders: Joanna Tengbom Hummel. The full history is accessible without an account.
3
Insider Decl.
0
Thresholds
€38,895
2 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
75.65 €
Analyst consensus
2 analysts80.00 €Target 90.00 €(+19%)100.00 €
Income statement
Revenue7.20 Bn€
Gross profit1.94 Bn€27% margin
Net income228.7 M€3.2% margin
Valuation
PER (trailing)33.3x
PER (forward)21.3x
P/Book8.5x
Balance sheet & cash
Market cap7.87 Bn€
Total debt331.0 M€
Free Cash Flow117.7 M€
Debt / Equity31%
Profitability & ownership
ROE28.3%
ROA9.4%
% insiders42.2%
% institutions56.4%
Last declaration on 18 March 2026
Declarations3 total
Executives●Purchase20FIN-FSA
€37,18435,907 shares@ €1.03560.0005% mcap100.0% of flow
Aktie
FI:A003X109-1·
Ideal exit: 12 Dec 2026 (T+270)
Executives●Purchase16FIN-FSA
€1,7121,672 shares@ €1.02380.0000% mcap100.0% of flow
Aktie
FI:A003U741-1·
Ideal exit: 11 Sept 2026 (T+270)
Executives●Other16FIN-FSA
€414,11640,000 shares@ €10.35290.0053% mcap100.0% of flow
Aktie
FI:A003R305-1·
3 of 3 declarations